Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Desmoid Tumors × Sarcoma × Clear all

Phase

Phase 2 15 Phase NA 9 Phase 1 7 Phase 3 4 Phase 1/2 3 Phase EARLY_PHASE1 1 Phase 4 1 Phase 2/3 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 8 Osteosarcoma 5 Bone Neoplasms 5 Neurofibrosarcoma 3 Liposarcoma 3 Leiomyosarcoma 3 Sarcoma, Synovial 2 Sarcoma, Ewing 2 Sarcoma, Alveolar Soft Part 2 Nerve Sheath Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Lymphoma 2 Lung Neoplasms 2 Histiocytoma, Malignant Fibrous 2 Gliosarcoma 2 Gastrointestinal Stromal Tumors 2 Fibrosarcoma 2 Chondrosarcoma, Extraskeletal Myxoid 2 Waldenstrom Macroglobulinemia 1 Thrombocythemia, Essential 1 Sezary Syndrome 1 Sarcoma, Clear Cell 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Perivascular Epithelioid Cell Neoplasms 1 Ovarian Neoplasms 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04871282 2026-02-05

RINGSIDE

Immunome, Inc.

Phase 2/3 Active not recruiting

Desmoid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡